10-Undecen-1-ol
CAS No. 112-43-6
10-Undecen-1-ol( —— )
Catalog No. M27520 CAS No. 112-43-6
10-Undecen-1-ol is converted from ricinoleic acid. 10-Undecen-1-ol can be used as a comonomer for the introduction of functional groups.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name10-Undecen-1-ol
-
NoteResearch use only, not for human use.
-
Brief Description10-Undecen-1-ol is converted from ricinoleic acid. 10-Undecen-1-ol can be used as a comonomer for the introduction of functional groups.
-
Description10-Undecen-1-ol is converted from ricinoleic acid. 10-Undecen-1-ol can be used as a comonomer for the introduction of functional groups.(In Vitro):Cobalt-catalyzed step growth polymerization of undec-10-en-1-ol and CO affords aliphatic polyesters (Mn > 10(4) g mol(-1)) based entirely on renewable resources.
-
In VitroCobalt-catalyzed step growth polymerization of undec-10-en-1-ol and CO affords aliphatic polyesters (Mn 104 g/mol) based entirely on renewable resources.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorplatelet-activating factor (PAF)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number112-43-6
-
Formula Weight170.296
-
Molecular FormulaC11H22O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (587.23 mM)
-
SMILESOCCCCCCCCCC=C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Herbert JM, et al. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist. J Pharmacol Exp Ther. 1991 Oct;259(1):44-51.
molnova catalog
related products
-
28-Homobrassinolide
28-high brassinolide is a natural product for research related to life sciences.
-
6-Hydroxy-2-(2-pheny...
6-Hydroxy-2-(2-phenylethyl)chromone is a natural product.
-
Bococizumab
Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to treat hypercholesterolemia.
Cart
sales@molnova.com